Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EMPIRe: iCM012 in DCD Kidney Transplantation
NCT06582485Phase 3Not yet recruiting
- Sponsor
- iCoat Medical
- Start
- Sep 2025
- Primary completion
- Dec 2026
- Modality
- Polymer-based Nanoparticles
01
Overview
A Phase 3 trial of iCM012 in ischemia-reperfusion injury (IRI), sponsored by iCoat Medical. Planned start Sep 2025; status: not yet recruiting.
02
Drugs
iCM012
03
Conditions
ischemia-reperfusion injury (IRI)
Beyond the preview
Go deeper on NCT06582485.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06582485.